Market Trends of Anthrax Vaccine Industry
Animal Use Anthrax Vaccine Segment is Expected to Hold a Significant Market Share Over the Forecast Period
- Anthrax is a disease of cattle and other ruminants that results in death in affected animals. It is a zoonotic disease that affects both humans and animals worldwide and is brought on by the soil-borne spore-forming bacteria Bacillus anthracis. The animal-use anthrax vaccine segment is expected to hold a significant market share over the forecast period owing to the increased awareness among animal owners regarding anthrax vaccination and rising initiatives by market players to develop animal vaccines.
- According to an article published in the Veterinary World Journal in April 2021, the prevalence of anthrax globally was 28% from 2452 samples through the fixed effects model. The random effects model's continent-by-subgroup study showed that the pooled prevalence of anthrax was highest in Africa (29%) and lowest in North America (21%). The spread of anthrax from infected animals to humans is one of the common modes of transmission of bacteria. Therefore, the high burden of anthrax in livestock animals globally is expected to propel the segment growth during the forecast period.
- Furthermore, the rising awareness among farm animal caretakers regarding their livestock animal anthrax vaccination is also contributing to the segment's growth during the forecast period. For instance, in May 2022, SDSU Extension and South Dakota Animal Industry Board veterinarians encouraged South Dakota cattle producers to include the anthrax vaccine in their vaccination program when they turn out cattle to summer pastures in the spring. These initiatives are projected to boost the anthrax vaccination utility in animals for the protection of their animals from lethal diseases and also reduce the transmission of bacteria to humans.
- Therefore, owing to the aforementioned factors, such as the high burden of anthrax in animals and rising anthrax vaccination initiatives for animals is projected to propel the segment growth during the forecast period.
Understand The Key Trends Shaping This Market
Download Sample
Asia-Pacific Holds a Significant Share in the Anthrax Vaccine Market Over The Forecast Period
- Asia-Pacific holds a significant share in the anthrax vaccine market over the forecast period owing to the high burden of anthrax in the region and rising consumption of undercooked/raw meat.
- An outbreak of anthrax was recorded in a few districts of Orissa (India), including Koraput, in 2021 and the past few years. In July 2021, the ICMR's Bhubaneswar Unit, the Regional Medical Research Centre (RMRC) - has commissioned a study to analyze the implementation of a 'One Health' intervention strategy in order to eradicate the deadly human anthrax by the year 2024 from the soils of tribal district Koraput. The study was expected to initiate a free routine vaccination program against anthrax in the district. Therefore, the implementation of vaccination programs to protect humans from deadly diseases is expected to propel market growth in the region.
- Additionally, as per a research article published in BMC Infectious Diseases Journal in November 2022, the human transmission of anthrax occurs via contact with infected animals through butchering and working with hides or consumption of raw or undercooked meat. The research study stated that the participation in slaughtering and cutting beef of sick cattle in Shandong Province, China, was significantly associated with cutaneous anthrax. Thus, the high probability of people consuming raw or uncooked meat infected with anthrax is anticipated to propel the market growth in the region during the forecast period.
- Therefore, owing to the aforementioned factors, such as the high burden of anthrax, rising vaccination programs, and a high proportion of people consuming raw or uncooked meat, the growth of the studied market is anticipated in the Asia Pacific Region.
Get Analysis on Important Geographic Markets
Download Sample
